UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against Candida auris

Pharmaceutics, 2021-08, Vol.13 (9), p.1333

2021

Volltextzugriff (PDF)

PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris

CPT: pharmacometrics and systems pharmacology, 2023-06, Vol.12 (6), p.770-782

2023

Volltextzugriff (PDF)

In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris

Antibiotics (Basel), 2021-03, Vol.10 (4), p.355

2021

Volltextzugriff (PDF)

In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida : A European Study

Frontiers in cellular and infection microbiology, 2022-05, Vol.12, p.906563-906563

2022

Volltextzugriff (PDF)

In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris

Pharmaceutics, 2021-10, Vol.13 (11), p.1767

2021

Volltextzugriff (PDF)

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis

PloS one, 2015-07, Vol.10 (7), p.e0132730-e0132730

2015

Volltextzugriff (PDF)

Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones

Antibiotics (Basel), 2023-05, Vol.12 (5), p.838

2023

Volltextzugriff (PDF)

Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model

Microbiology spectrum, 2024-01, Vol.12 (1), p.e0208623-e0208623

2024

Volltextzugriff (PDF)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates

Journal of fungi (Basel), 2023-06, Vol.9 (6), p.648

2023

Volltextzugriff (PDF)

Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

Journal of fungi (Basel), 2022-07, Vol.8 (7), p.727

2022

Volltextzugriff (PDF)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs

Medicina oral, patología oral y cirugía bucal, 2019-03, Vol.24 (2), p.e172-e180

2019

Volltextzugriff (PDF)

In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3615-3618

2015

Volltextzugriff (PDF)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against ICandida auris/I Isolates

Journal of fungi (Basel), 2023-06, Vol.9 (6)

2023

Volltextzugriff (PDF)

Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades

Diagnostic microbiology and infectious disease, 2016-10, Vol.86 (2), p.172-177

2016

Volltextzugriff (PDF)

Comparison of the in vitro activity of echinocandins against Candida albicans , Candida dubliniensis , and Candida africana by time–kill curves

Diagnostic microbiology and infectious disease, 2015-05, Vol.82 (1), p.57-61

2015

Volltextzugriff (PDF)

Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity

Revista iberoamericana de micología, 2019-01, Vol.36 (1), p.24-29

2019

Volltextzugriff (PDF)

Postantifungal effect of anidulafungin against Candida albicans, Candida dubliniensis, Candida africana, Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis

Revista española de quimioterapia, 2019-04, Vol.32 (2), p.183-188

2019

Volltextzugriff (PDF)

In vitro pharmacodynamic modelling of anidulafungin against Candida spp

International journal of antimicrobial agents, 2016-03, Vol.47 (3), p.178-183

2016

Volltextzugriff (PDF)

Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis

Expert review of anti-infective therapy, 2013-04, Vol.11 (4), p.347-358

2013

Volltextzugriff (PDF)

Combination antifungal therapy: a strategy for the management of invasive fungal infections

Revista española de quimioterapia, 2014-09, Vol.27 (3), p.141-158

2014

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine

Clinical pharmacokinetics, 2009-01, Vol.48 (8), p.543-554

2009

Volltextzugriff (PDF)

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis: e0132730

PloS one, 2015-07, Vol.10 (7)

2015

Volltextzugriff (PDF)

Farmako antipsikotikoak eta aho-patologia: eragin kaltegarriak jakinarazteko Europako sistemaren bidezko analisia

Osagaiz: osasun-zientzien aldizkaria, 2023-11, Vol.6 (1)

2023

Volltextzugriff (PDF)

Clinical usefulness of triazole derivatives in the management of fungal infections

Revista española de quimioterapia, 2015-08, Vol.28 (4), p.169

2015

Volltextzugriff (PDF)

Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model

Pharmaceutical research, 2005-11, Vol.22 (11), p.1769-1782

2005

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against Candida auris

PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris

In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris

In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida : A European Study

In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis

Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones

Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates

Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

Therapeutic tools for oral candidiasis: Current and new antifungal drugs

In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against ICandida auris/I Isolates

Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades

Comparison of the in vitro activity of echinocandins against Candida albicans , Candida dubliniensis , and Candida africana by time–kill curves

Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity

Postantifungal effect of anidulafungin against Candida albicans, Candida dubliniensis, Candida africana, Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis

In vitro pharmacodynamic modelling of anidulafungin against Candida spp

Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis

Combination antifungal therapy: a strategy for the management of invasive fungal infections

Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis: e0132730

Farmako antipsikotikoak eta aho-patologia: eragin kaltegarriak jakinarazteko Europako sistemaren bidezko analisia

Clinical usefulness of triazole derivatives in the management of fungal infections

Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model

Suchergebnisse filtern